Vireo Growth (VREOF) Selling, General & Administrative (2020 - 2026)

Vireo Growth (VREOF) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Haleon 89.78 Bn 87.91 Bn - -
2 Teva Pharmaceutical Industries 35.95 Bn 32.21 Bn 1.97 Bn 304.00 Mn
3 Zoetis 32.53 Bn 30.59 Bn 1.62 Bn 588.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 5.21 Bn
5 United Therapeutics 22.99 Bn 20.84 Bn 648.10 Mn 184.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.42 Bn 18.61 Bn 1.16 Bn 928.80 Mn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn 318.50 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn 381.00 Mn
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn 30.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.80 Mn
Dec 31, 2025 31.58 Mn
Sep 30, 2025 29.68 Mn
Jun 30, 2025 12.45 Mn
Mar 31, 2025 7.40 Mn
Dec 31, 2024 6.54 Mn
Sep 30, 2024 6.91 Mn
Jun 30, 2024 7.56 Mn
Mar 31, 2024 7.05 Mn
Dec 31, 2023 6.25 Mn
Sep 30, 2023 6.75 Mn
Jun 30, 2023 8.06 Mn
Mar 31, 2023 7.16 Mn
Dec 31, 2022 7.43 Mn
Sep 30, 2022 8.49 Mn
Jun 30, 2022 8.63 Mn
Mar 31, 2022 9.28 Mn
Dec 31, 2021 9.21 Mn
Sep 30, 2021 8.11 Mn
Jun 30, 2021 8.30 Mn